Literature DB >> 3491785

Dietary fat influences the expression of autoimmune disease in MRL/lpr/lpr mice.

W J Morrow, J Homsy, C A Swanson, Y Ohashi, J Estes, J A Levy.   

Abstract

Near-isocaloric diets with qualitative and quantitative differences in fat content have a profound influence on the manifestation and progression of the autoimmune syndrome that occurs in female MRL/lpr mice. In these animals, a high (9%) lipid intake resulted in a significantly higher mortality rate: 60% (saturated fat) and 75% (unsaturated fat) compared to 35% at 1 year for a group fed a diet low in fat. Furthermore, beginning at 7 months of age mice from both of the high fat diet groups exhibited a significantly higher incidence of proteinuria than mice in the low fat group. Immunologically, the group fed the high unsaturated fat diet had the highest incidence of anti-dsDNA autoantibodies, and the high saturated fat group had the poorest macrophage phagocytic function. The low fat diet preserved near 'normal' immune function in general, particularly IL-2 production. No significant differences were noted in either the production of rheumatoid factor or natural killer cell activity, irrespective of age or diet.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491785      PMCID: PMC1453202     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

Review 1.  Nutrition and autoimmunity: a review.

Authors:  J Homsy; W J Morrow; J A Levy
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

2.  Influence of early or late dietary restriction on life span and immunological parameters in MRL/Mp-lpr/lpr mice.

Authors:  C Kubo; N K Day; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Effect of calorie restriction on the production and responsiveness to interleukin 2 in (NZB X NZW)F1 mice.

Authors:  L K Jung; M A Palladino; S Calvano; D A Mark; R A Good; G Fernandes
Journal:  Clin Immunol Immunopathol       Date:  1982-11

4.  Macrophage fatty acid composition and phagocytosis: effect of unsaturation on cellular phagocytic activity.

Authors:  A J Schroit; R Gallily
Journal:  Immunology       Date:  1979-02       Impact factor: 7.397

5.  Interleukin 2 deficiency is a common feature of autoimmune mice.

Authors:  M J Dauphinée; S B Kipper; D Wofsy; N Talal
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

6.  Dietary fat affects immune response, production of antiviral factors, and immune complex disease in NZB/NZW mice.

Authors:  J A Levy; A B Ibrahim; T Shirai; K Ohta; R Nagasawa; H Yoshida; J Estes; M Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Analysis of lymphocyte subsets in the blood of rheumatoid arthritis patients: correlation with disease activity.

Authors:  P Y Youinou; P Le Goff; W J Morrow; P Miossec; Y Pennec
Journal:  J Rheumatol       Date:  1983-10       Impact factor: 4.666

8.  Dietary fat and immune function. II. Effects on immune complex nephritis in (NZB x NZW)F1 mice.

Authors:  W Yumura; S Hattori; W J Morrow; D C Mayes; J A Levy; T Shirai
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

9.  Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.

Authors:  A Altman; A N Theofilopoulos; R Weiner; D H Katz; F J Dixon
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene.

Authors:  D Wofsy; E D Murphy; J B Roths; M J Dauphinée; S B Kipper; N Talal
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  6 in total

1.  Effect of low dietary lipid on the development of Sjögren's syndrome and haematological abnormalities in (NZB x NZW)F1 mice.

Authors:  C A Swanson; J A Levy; W J Morrow
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

Review 2.  Enteral nutrition as primary therapy in Crohn's disease.

Authors:  F Fernández-Bañares; E Cabré; F González-Huix; M A Gassull
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

3.  A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease.

Authors:  K Leiper; J Woolner; M M Mullan; T Parker; M van der Vliet; S Fear; J M Rhodes; J O Hunter
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

Review 4.  Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3.

Authors:  Laurence S Harbige
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

5.  Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.

Authors:  F González-Huix; R de León; F Fernández-Bañares; M Esteve; E Cabré; D Acero; A Abad-Lacruz; M Figa; M Guilera; R Planas
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

6.  The genetic regulation of the induction of experimental SLE.

Authors:  S Mendlovic; S Brocke; H Fricke; Y Shoenfeld; R Bakimer; E Mozes
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.